Patents by Inventor Im Hee SHIN

Im Hee SHIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10342835
    Abstract: The present invention relates to a composition for promoting proliferation of bone marrow derived stem cells using an angelicae gigantis radix extract, and more particularly, to a composition which administers a granulocyte colony-stimulating factor into an object, and administers the angelicae gigantis radix extract to the object to promote the proliferation of the bone marrow derived stem cells. The composition of the present invention solves side effects such as splenomegaly which were caused by a method of administering only the G-CSF for proliferation and differentiation of the stem cells, thereby significantly mitigating the side effects through co-administration of the angelicae gigantis radix extract, and further promoting the proliferation and the differentiation of the stem cells.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: July 9, 2019
    Assignee: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTE
    Inventors: Chang Hyeong Lee, Sang Gyung Kim, Im Hee Shin, Seung Mo Kim, Joon Seok Byun, Ki Cheul Sohn, Sae Kwang Ku
  • Patent number: 10286040
    Abstract: The present invention relates to a composition for promoting the proliferation of stem cells derived from bone marrow using a palmultang extract, and more specifically, to a composition for promoting the proliferation of stem cells derived from bone marrow by administering a granulocyte colony-stimulating factor to a subject and then administering the palmultang extract to the subject. The composition of the present invention remarkably reduces side effects, such as enlargement of the spleen, which are caused by the administration of G-CSF alone for proliferation and differentiation of the stem cells, through administration in combination with the palmultang extract, thereby further promoting the proliferation and differentiation of stem cells.
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: May 14, 2019
    Assignee: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTE
    Inventors: Chang Hyeong Lee, Sang Gyung Kim, Im Hee Shin, Seung Mo Kim, Joon Seok Byun, Ki Cheul Sohn, Sae Kwang Ku
  • Publication number: 20180243358
    Abstract: The present invention relates to a composition for promoting proliferation of bone marrow derived stem cells using an angelicae gigantis radix extract, and more particularly, to a composition which administers a granulocyte colony-stimulating factor into an object, and administers the angelicae gigantis radix extract to the object to promote the proliferation of the bone marrow derived stem cells. The composition of the present invention solves side effects such as splenomegaly which were caused by a method of administering only the G-CSF for proliferation and differentiation of the stem cells, thereby significantly mitigating the side effects through co-administration of the angelicae gigantis radix extract, and further promoting the proliferation and the differentiation of the stem cells.
    Type: Application
    Filed: May 2, 2018
    Publication date: August 30, 2018
    Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTE
    Inventors: Chang Hyeong LEE, Sang Gyung KIM, Im Hee SHIN, Seung Mo KIM, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU
  • Publication number: 20180185447
    Abstract: The present invention relates to a composition for promoting the proliferation of stem cells derived from bone marrow using a palmultang extract, and specifically, to a composition for promoting the proliferation of stem cells derived from bone marrow by administering a granulocyte colony-stimulating factor to a subject and then administering the palmultang extract to the subject. The composition of the present invention remarkably reduces side effects, such as enlargement of the spleen, which are caused by the administration of G-CSF alone for proliferation and differentiation of the stem cells, through administration in combination with the palmultang extract, thereby further promoting the proliferation and differentiation of stem cells.
    Type: Application
    Filed: December 26, 2017
    Publication date: July 5, 2018
    Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTE
    Inventors: Chang Hyeong LEE, Sang Gyung KIM, Im Hee SHIN, Seung Mo KIM, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU
  • Publication number: 20160101156
    Abstract: The present invention relates to a composition for promoting the proliferation of stem cells derived from bone marrow using a palmultang extract, and more specifically, to a composition for promoting the proliferation of stern cells derived from bone marrow by administering a granulocyte colony-stimulating factor to a subject and then administering the palmultang extract to the subject. The composition of the present invention remarkably reduces side effects, such as enlargement of the spleen, which are caused by the administration of G-CSF alone for proliferation and differentiation of the stern cells, through administration in combination with the palmultang extract, thereby further promoting the proliferation and differentiation of stem cells.
    Type: Application
    Filed: May 1, 2014
    Publication date: April 14, 2016
    Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTE
    Inventors: Chang Hyeong LEE, Sang Gyung KIM, Im Hee SHIN, Seung Mo KIM, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU
  • Publication number: 20160058810
    Abstract: The present invention relates to a composition for promoting proliferation of bone marrow derived stem cells using an angelicae gigantis radix extract, and more particularly, to a composition which administers a granulocyte colony-stimulating factor into an object, and administers the angelicae gigantis radix extract to the object to promote the proliferation of the bone marrow derived stem cells. The composition of the present invention solves side effects such as splenomegaly which were caused by a method of administering only the G-CSF for proliferation and differentiation of the stem cells, thereby significantly mitigating the side effects through co-administration of the angelicae gigantis radix extract, and further promoting the proliferation and the differentiation of the stem cells.
    Type: Application
    Filed: May 1, 2014
    Publication date: March 3, 2016
    Applicant: COMPREHENSIVE AND INTEGRATIVE MEDICINE INSTITUTE
    Inventors: Chang Hyeong LEE, Sang Gyung KIM, Im Hee SHIN, Seung Mo KIM, Joon Seok BYUN, Ki Cheul SOHN, Sae Kwang KU